Physician profile
Terry Mark Roman
NPI 1083895312
$18,210.15
in general payments reported to CMS, 2019-2025
8 companies · $2,450 in 2025
The $2,450 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,296 · 2020: $2,678 · 2021: $3,958 · 2023: $1,051 · 2024: $777 · 2025: $2,450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,129 · Food and Beverage: $1,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,128.66 |
| Food and Beverage | $1,149.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,915.62 | 2019-2025 | |
| Great Lakes Orthopedics | $5,369.28 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $2,304.26 | 2019-2023 | Comprehensive Shoulder System, Juggerknotless Soft Anchor |
| Stryker Corporation | $777.26 | 2024 | Mako, Gamma, Variax |
| Enduromed, LLC | $693.48 | 2025 | |
| Innovation Technologies INC | $101.53 | 2021 | |
| Lightbody Medical Technologies INC | $30.36 | 2025 | |
| Smith+Nephew, INC. | $18.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Roman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.